Cargando…
Fibrin Clot Structure and Platelet Aggregation in Patients with Aspirin Treatment Failure
BACKGROUND: Aspirin is a cornerstone in prevention of cardiovascular events and modulates both platelet aggregation and fibrin clot formation. Some patients experience cardiovascular events whilst on aspirin, often termed aspirin treatment failure (ATF). This study evaluated both platelet aggregatio...
Autores principales: | Neergaard-Petersen, Søs, Ajjan, Ramzi, Hvas, Anne-Mette, Hess, Katharina, Larsen, Sanne Bøjet, Kristensen, Steen Dalby, Grove, Erik Lerkevang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747207/ https://www.ncbi.nlm.nih.gov/pubmed/23976993 http://dx.doi.org/10.1371/journal.pone.0071150 |
Ejemplares similares
-
The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with Aspirin
por: Neergaard-Petersen, Søs, et al.
Publicado: (2015) -
Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease
por: Larsen, Sanne Bøjet, et al.
Publicado: (2015) -
Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease
por: Larsen, Sanne Bøjet, et al.
Publicado: (2017) -
Coronary artery disease-associated genetic variants and biomarkers of inflammation
por: Christiansen, Morten Krogh, et al.
Publicado: (2017) -
Calprotectin and Platelet Aggregation in Patients with Stable Coronary Artery Disease
por: Larsen, Sanne Bøjet, et al.
Publicado: (2015)